aglatimagene besadenovec + valacyclovir

Drug identity checked against registry records

Also recorded as CAN-2409 plus prodrug

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecNCT07332000CADLPhase 2Recruiting2027-02Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.